Apollo gains CE marking for new endoscopic indications, with the OverStitch system, including ESGApollo Endosurgery has gained CE marking for new endoscopic indications, with the OverStitch system, including endoscopic gastric sleeve...
Boston Scientific agree to acquire Apollo Endosurgery for US$615 millionBoston Scientific has entered into a definitive agreement to acquire Apollo Endosurgery, for a cash price of $10 per share, reflecting an...
Apollo’s ESG and REVISE Systems approved by FDAApollo Endosurgery has been granted marketing authorisation for its ESG, ESG Sx, REVISE and REVISE Sx through the FDA’s De Novo...
MERIT: Endoscopic sleeve gastroplasty study meets primary endpointsStudy investigators of the Multi-Center Endoscopic Sleeve Gastroplasty (ESG) Randomized Interventional Trial (MERIT) have announced that...
MERIT: ESG achieves primary efficacy and safety endpointsInvestigators of the Multi-Center ESG Randomized Interventional (MERIT) study, which is comparing Endoscopic Sleeve Gastroplasty (ESG) to...
X-Tack is superior for acute closure of large resection defects vs TTS clipsRescue therapy with X-Tack following failed closure with TTS clips and X-Tack closure of a colonic perforation. a Failed closure attempt...
Apollo Endosurgery gains CPT Codes for use in intragastric balloon proceduresApollo Endosurgery has gained the assignment of Category I Current Procedural Terminology (CPT) codes with short form descriptor...